Literature DB >> 32754211

Interobserver Agreement in Assessing Dysplasia in Colorectal Adenomatous Polyps: A Multicentric Iranian Study.

Tahmineh Mollasharifi1, Mahsa Ahadi2, Elena Jamali3, Afshin Moradi4, Parisa Asghari1, Saman Maroufizadeh5, Behrang Kazeminezhad1.   

Abstract

BACKGROUND &
OBJECTIVE: Most colorectal cancers (CRCs) arise from adenomatous polyps, and clinical management of this type of polyp is highly dependent on the reliability and validity of the pathological diagnosis. The aim of this study was to examine the interobserver agreement of five pathologists in assessing dysplasia in adenomatous polyps.
METHODS: In this study, a total of 146 adenomatous polyps of patients undergoing colonoscopy were selected from hospitals of Shahid Beheshti University of Medical Sciences, Tehran, Iran between 2017 and 2018. Five pathologists independently classified adenomatous polyps according to histologic type, nuclear pseudostratification, mitotic activity, nuclear polarity, nuclear pleomorphism, nuclear shape, nucleolus, chromatin pattern, cytology grade, architectural features, dysplasia, and final diagnosis. The overall kappa statistic (k) was used to assess agreement among pathologists.
RESULTS: The mean age of the patients was 62.06 ± 13.06 (mean ± SD) with a male-to-female ratio of 2.2:1. The most common site of resection was the sigmoid colon (28.1%). The highest agreement was found for dysplasia grade (k=0.415) and histologic type (k=0.401), whereas the lowest agreement was found for mitotic activity (k=0.185), nuclear shape (k=0.187), and nucleolus (k=0.196).
CONCLUSION: Our findings indicate that agreement among pathologists in assessing dysplasia in adenomatous polyps is within fair to moderate levels of agreement. Therefore, there is a vital need to better clarify the current diagnostic criteria.

Entities:  

Keywords:  Adenomatous polyp; Colorectal cancer; Dysplasia; Histopathology; Interobserver agreement

Year:  2020        PMID: 32754211      PMCID: PMC7354064          DOI: 10.30699/ijp.2020.115021.2250

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


Introduction

Colorectal cancer (CRC) is the fifth most common cancer and the fourth leading cause of cancer-related death in Iran (1). Most CRCs arise from adenomatous polyps (2), and scientific studies have shown that a considerable reduction of the incidence and mortality of CRC can be achieved by removing adenomatous polyps before their potential progress to adenocarcinomas (3). Currently, in several countries, colonoscopy is the primary modality to detect and remove adenomatous polyps and can be considered as the best method for this purpose (4). Previous observational studies have shown that several characteristic features of adenomas might be associated with the risk of CRC. Most often cited features include the size, number, grade of dysplasia, and histologic type. Therefore, appropriate clinical management of the adenomatous polyps depends on the reliability and validity of the pathological diagnosis. In addition, as many countries have implemented or are preparing nationwide CRC screening (5,6), reliable and valid histopathological measurement of colorectal polyps is of paramount importance. Previous studies have indicated moderate degrees of interobserver agreement in the histopathological assessments of colorectal adenomas (7–11), and thus concern has been expressed about the reproducibility of the histopathological interpretation among the pathologists. This study, therefore, aimed to examine the interobserver agreement of five pathologists in assessing dysplasia in adenomatous polyps.

Materials and Methods

Patients and Study Design In this study, a series of 146 adenomatous polyps of patients undergoing colonoscopy for the first time were examined. One of the authors prescreened archival hematoxylin and eosin (H&E) slides of colorectal adenomas obtained at Shahid Beheshti Medical Sciences Affiliated Hospitals. These polyps were resected by polypectomy. Specimens were selected from ordinary daily cases of pathology department centers with a high number of gastrointestinal (GI) pathology cases in several hospitals affiliated to Shahid Beheshti University of Medical Sciences, Tehran, Iran between 2017 and 2018. Demographic data, including age, sex, and location of polyps, were extracted from the pathology request form and patient’s medical files. Five pathologists (named Pathologist 1, 2, 3, 4, and 5 in the study) reviewed the entire set of slides of the 146 adenomatous polyps. These pathologists were the faculty members of the pathology department practicing GI pathology in their daily routine. Two are associate professors, and three of them are assistant professors. The pathologists were blind to the original diagnosis of adenomatous polyps. The following features were gathered: histologic type, nuclear pseudostratification, mitotic activity, nuclear polarity, nuclear pleomorphism, nuclear shape, nucleolus, chromatin pattern, cytology grade, architectural patterns, degree of dysplasia, and final diagnosis. Dysplasia grading of adenomas was defined as high-grade and low-grade based on the cytological and architectural features. Low-grade dysplasia is defined by the presence of architecturally noncomplex crypts containing nuclei that are pseudostratified or partially stratified, and the nuclei reach only the lower half of the cytoplasm. High-grade dysplasia is interpreted by marked pseudostratification or stratification of neoplastic nuclei that extend up to the luminal half of the cells and usually contain significant pleomorphism, increased mitotic activity, atypical mitoses, and marked loss of polarity. Architectural changes, including back-to-back gland configuration and cribriforming, may also be seen. With the progression of neoplasia, glands become more irregular and complex. Moreover, neoplastic nuclei become more “open” in appearance and may contain prominent nucleoli (12). Villous architecture is defined as leaflike or fingerlike projections of epithelium overlying a small amount of lamina propria. Tubulovillous adenomas are defined by a mixture of tubular and villous structures, with arbitrary percentages in different studies, typically with between 25% and 75% villous component (13). In our study, the percentage between 20% and 80% was defined for the former purpose. Besides, pathologists were asked to fill out the predefined checklist without discussing their answers with each other. Ethical Consideration The Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran approved this study (Registration Number: IR.SBMU.RETECH.REC.1397.316). All patients were informed about the aim of the study, and informed consent was obtained from all patients before participation in this study. Statistical Analysis In the present study, continuous variables were presented as mean (standard deviation) and categorical variables as number (percentage). The overall kappa statistic (k) was used to assess agreement among pathologists. The kappa value ranges from -1 to 1. The higher the value of kappa, the stronger the agreement. A kappa value of 0 indicates that the agreement is the same as would be expected by chance. The strength of agreement for the kappa value can be interpreted as follows: < 0.20, poor; 0.21-0.40, fair; 0.41- 0.60, moderate; 0.61-0.80, good; 0.81-1.00, very good. All data analyses were performed by using Minitab release 14.0 (Minitab Inc. State College, PA, USA).

Results

Patients’ Characteristics The mean age of the patients was 62.06 ± 13.06 (mean±SD). One hundred (68.5%) patients were male and 46 (31.5%) were female. As for the location in the colon, the most common site of resection was the sigmoid colon (28.1%), followed by the descending colon (18.5%), as well as transverse colon (17.1%), rectum (13.7%), and ascending colon (11.0%) (Table 1).
Table 1

Demographic and clinical characteristics of the patients undergoing colonoscopy for the first time (n = 146).

Variablen (%) or mean ± SD
Age (years)62.06 ± 13.06
Sex
Male100 (68.5%)
Female46 (31.5%)
Site of resection (Location of adenomas)
Rectum20 (13.7)
Sigmoid colon41 (28.1)
Ascending colon16 (11.0)
Descending colon27 (18.5)
Transverse colon25 (17.1)
Cecum6 (4.1)
Rectosigmoid7 (4.8)
Colon (Unclassified)4 (2.7)

SD: Standard Deviation

Characteristics of the Adenomatous Polyps Classification of adenomatous polyps based on the histologic type (i.e., tubular, tubulovillous, and villous) was considerably different among the five pathologists. Most of the polyps were tubular adenomas, and the prevalence of this type ranged from 54.8% (for Pathologist 5) to 86.3% (for Pathologist 4). The observed distribution of adenomas, according to dysplasia grade, was also significantly different across the five pathologists. Most of the patients had low-grade dysplasia with a prevalence ranging from 79.5% (for Pathologist 5) to 98.6% (for Pathologist 4). Similar to histologic type and dysplasia grade, considerable variability was observed among pathologists in the histopathological assessments of adenomas according to other characteristics (Tables 2 and 3).
Table 2

Characteristics of the 146 adenomatous polyps according to the five pathologists’ assessments

Pathologist
P1P2P3P4P5
Histologic type
Tubular100 (68.5)111 (76.0)104 (71.2)126 (86.3)80 (54.8)
Tubulovillous37 (25.3)31 (21.2)35 (24.0)15 (10.3)60 (41.1)
Villous9 (6.2)4 (2.7)7 (4.8)5 (3.4)6 (4.1)
Nuclear Pseudostratification
Limited to the lower half131 (89.7)108 (74.0)128 (87.7)115 (78.8)92 (63.0)
Extended to luminal half15 (10.3)38 (26.0)18 (12.3)31 (21.2)54 (37.0)
Mitotic Activity
Typical (Mild)129 (88.4)126 (86.3)136 (93.2)124 (84.9)113 (77.4)
Typical (Moderate)16 (11.0)16 (11.0)10 (6.8)20 (13.7)33 (22.6)
Typical (Brisk)1 (0.7)2 (1.4)-2 (1.4)-
Atypical-2 (1.4)---
Nuclear Polarity
Mildly distorted127 (87.0)103 (70.5)134 (91.8)137 (93.8)130 (89.0)
Moderately distorted18 (12.3)33 (22.6)12 (8.2)9 (6.2)16 (11.0)
Severally distorted1 (0.7)10 (6.8)---
Nuclear Pleomorphism
Mild112 (76.7)104 (71.2)131 (89.7)113 (77.4)126 (86.3)
Moderate33 (22.6)37 (25.3)15 (10.3)32 (21.9)20 (13.7)
Severe1 (0.7)5 (3.4)-1 (0.7)-
Nuclear shape
Elongated121 (82.9)91 (62.3)126 (86.3)105 (71.9)79 (54.1)
Round11 (7.5)15 (10.3)3 (2.1)1 (0.7)18 (12.3)
Mixed14 (9.6)40 (27.4)17 (11.6)40 (27.4)49 (33.6)
Chromatin Pattern
Open9 (6.2)15 (10.3)8 (5.5)-34 (23.3)
Hyperchrome115 (78.8)90 (61.6)108 (74.0)94 (64.4)70 (47.9)
Mixed22 (15.1)41 (28.1)30 (20.5)52 (35.6)42 (28.8)
Nucleolus
Not seen103 (70.5)96 (65.8)117 (80.1)110 (75.3)65 (44.5)
Small33 (22.6)27 (18.5)19 (13.0)34 (23.3)57 (39.0)
Medium10 (6.8)16 (11.0)9 (6.2)2 (1.4)22 (15.1)
Large-7 (4.8)1 (0.7)-2 (1.4)
Cytology Grade- Upper Half
Low-grade122 (83.6)113 (77.4)126 (86.3)140 (95.9)102 (69.9)
High-grade24 (16.4)33 (22.6)20 (13.7)6 (4.1)44 (30.1)
Cytology Grade- Lower Half
Low-grade136 (93.2)129 (88.4)131 (89.7)145 (99.3)129 (88.4)
High-grade10 (6.8)17 (11.6)15 (10.3)1 (0.7)17 (11.6)
Dysplasia Grade
Low-grade125 (85.6)127 (87.0)125 (85.6)144 (98.6)116 (79.5)
High-grade21 (14.4)19 (13.0)21 (14.4)2 (1.4)30 (20.5)
Final Diagnosis
Low grade- Tubular97 (66.4)99 (67.8)96 (65.8)125 (85.6)71 (48.6)
High grade- Tubular3 (2.1)12 (8.2)8 (5.5)1 (0.7)9 (6.2)
Low grade- Tubulovillous23 (15.8)26 (17.8)24 (16.4)15 (10.3)43 (29.5)
High grade- Tubulovillous14 (9.6)5 (3.4)11 (7.5)-17 (11.6)
Low grade- Villous5 (3.4)2 (1.4)5 (3.4)4 (2.7)2 (1.4)
High grade- Villous4 (2.7)2 (1.4)2 (1.4)1 (0.7)4 (2.7)

Values are presented as n (%).

Table 3

Architectural features of the 146 adenomatous polyps according to the five pathologists’ assessments

Pathologist
P1P2P3P4P5
Grade of Architecture- Upper Half
Low-grade123 (84.2)126 (86.3)126 (86.3)145 (99.3)115 (78.8)
High-grade23 (15.8)20 (13.7)20 (13.7)1 (0.7)31 (21.2)
Grade of Architecture- Lower Half
Low-grade137 (93.8)132 (90.4)132 (90.4)144 (98.6)140 (95.9)
High-grade9 (6.2)14 (9.6)14 (9.6)2 (1.4)6 (4.1)
Crypts Configuration
Parallel119 (81.5)127 (87.0)127 (87.0)133 (00.0)99 (67.8)
Back-to-back13 (8.9)5 (3.4)8 (5.5)-7 (4.8)
Cribriforming1 (0.7)2 (1.4)2 (1.4)-1 (0.7)
Complex Budding2 (1.4)2 (1.4)2 (1.4)-4 (2.7)
Combined11 (7.5)10 (6.8)7 (4.8)13 (8.9)35 (24.0)

Values are presented as n (%).

Interobserver Agreement In our study, the highest agreement was found for dysplasia grade (k=0.415) and histologic type (k=0.401), whereas the lowest agreement was found for mitotic activity (k=0.185), nuclear shape (k=0.187), and nucleolus (k=0.196). A perfect agreement on histologic type (i.e., all pathologists' assessments agree with each other) among the five pathologists was obtained for 75 polyps (51.4%). More specifically, it was obtained for 68 tubular adenomas, five tubulovillous adenomas, and two villous adenomas. The overall kappa value was 0.401, which is considered to be moderate. After excluding the assessment of Pathologist 4, Pathologist 5, and both, the overall kappa values increased to 0.445, 0.440, and 0.511, respectively. Demographic and clinical characteristics of the patients undergoing colonoscopy for the first time (n = 146). SD: Standard Deviation Characteristics of the 146 adenomatous polyps according to the five pathologists’ assessments Values are presented as n (%). Architectural features of the 146 adenomatous polyps according to the five pathologists’ assessments Values are presented as n (%). Interobserver agreement in the histopathological assessment of colorectal adenomatous polyps An overall agreement among the five pathologists based on the cytology grade in both the upper and lower halves was obtained for 89 (61.0%) and 117 (80.1%) polyps, respectively. The overall kappa values in the upper and lower halves, respectively, were 0.352 and 0.374, which are considered to be fair. After excluding the assessment of Pathologist 4, the overall kappa values for the upper and lower halves considerably increased to 0.427 and 0.504, respectively. Regarding the grade of architecture in both the upper and lower halves, an overall agreement among the five pathologists was obtained for 101 (69.2%) and 123 (84.2%) polyps, respectively. The overall kappa values in the upper and lower halves, respectively, were 0.365 and 0.325, which are considered to be fair. After excluding the assessment of Pathologist 4, the overall kappa values for the upper half considerably increased to 0.495. Moreover, after excluding the assessment of both Pathologists 4 and 5, the overall kappa values for the lower half significantly increased to 0.587. Among the 146 adenomas, the overall agreement for crypts’ configuration was obtained in 83 polyps (56.9%). Interobserver agreement was fair, with a kappa value of 0.253. Regarding the dysplasia grade, a perfect agreement among the five pathologists was obtained for 104 polyps (71.2%). The overall kappa value was 0.415, which is considered to be moderate. Despite the overall favorable kappa value for grading of dysplasia, a number of discrepancies were identified, so after excluding the assessment of Pathologist 4 and both Pathologists 4 and 5, the overall kappa values increased to 0.536 and 0.581, respectively. A case of tubulovillous adenoma's illustration with disagreement in grade of dysplasia is presented in Figures 1, 2, and 3.
Fig. 1

H&E stain (x40): All pathologist's diagnosis was tubulovillus adenoma for above figure, but there was disagreement for grade of dysplasia. Two high grade and three low grade diagnosis were made

Fig. 2

H&E stain (x40): Architecture of crypts diagnosed parallel by two pathologists so as low-grade dysplasia, while diagnosed as back to back and complex by other three pathologists who considered same case as tubulovillous adenoma with high grade dysplasia

Fig. 3

H&E stain (x100): Cytology grade considered high by two pathologists, while diagnosed as low grade by three pathologists

H&E stain (x40): All pathologist's diagnosis was tubulovillus adenoma for above figure, but there was disagreement for grade of dysplasia. Two high grade and three low grade diagnosis were made H&E stain (x40): Architecture of crypts diagnosed parallel by two pathologists so as low-grade dysplasia, while diagnosed as back to back and complex by other three pathologists who considered same case as tubulovillous adenoma with high grade dysplasia H&E stain (x100): Cytology grade considered high by two pathologists, while diagnosed as low grade by three pathologists The overall agreement for the final diagnosis (i.e., both the histologic type and dysplasia grade) of adenomas was obtained in 61 polyps (41.8%). The overall kappa value was 0.344, which is considered to be fair. Interobserver agreement for other features of adenomatous polyps is presented in Table 4.
Table 4

Interobserver agreement in the histopathological assessment of colorectal adenomatous polyps

CharacteristicsAll pathologists(P1, P2, P3, P4, and P5)All pathologist except P4(P1, P2, P3, and P5)All pathologist except P5(P1, P2, P3, and P4)All pathologist except P4 and P5 (P1, P2, P3)
Complete Agreement, n (%)Overall KappaComplete Agreement, n (%)Overall KappaComplete Agreement, n (%)Overall KappaComplete Agreement, n (%)Overall Kappa
Histologic type75 (51.4)0.40181 (55.5)0.44592 (63.0)0.440101 (69.2)0.511
Nuclear Pseudostratification72 (49.3)0.25083 (56.9)0.31189 (61.0)0.256110 (75.3)0.395
Mitotic Activity87 (59.6)0.18596 (65.7)0.22099 (67.8)0.145115 (78.8)0.258
Nuclear Polarity91 (62.3)0.21793 (63.7)0.21894 (64.4)0.19197 (64.4)0.184
Nuclear Pleomorphism81 (55.5)0.30592 (63.0)0.32984 (57.5)0.28396 (65.5)0.297
Nuclear shape48 (32.9)0.18758 (39.7)0.18568 (46.6)0.22487 (59.6)0.255
Chromatin Pattern44 (30.1)0.22651 (34.9)0.22360 (41.1)0.26979 (54.1)0.298
Nucleolus44 (33.1)0.19651 (34.9)0.22470 (47.9)0.24281 (55.5)0.279
Cytology Grade- Upper Half89 (61.0)0.35296 (65.7)0.427106 (72.6)0.396114 (78.1)0.496
Cytology Grade- Lower Half117 (80.1)0.374122 (83.6)0.504121 (82.9)0.339127 (87.0)0.500
Grade of Architecture-Upper Half101 (69.2)0.365109 (74.7)0.493110 (75.3)0.331119 (81.5)0.499
Grade of Architecture-Lower Half123 (84.2)0.325124 (84.9)0.406126 (86.3)0.423132 (90.4)0.587
Crypts Configuration83 (56.9)0.25388 (60.3)0.298104 (71.2)0.292113 (77.4)0.418
Dysplasia Grade104 (71.2)0.415112 (76.7)0.536115 (78.8)0.413124 (84.9)0.581
Final Diagnosis61 (41.8)0.34467 (45.9)0.40779 (54.1)0.37088 (60.27)0.454

Discussion

The aim of this study was to assess interobserver variability in the classification of dysplasia in colorectal adenomas among Iranian pathologists. In this study, a total of 146 adenomatous polyps were histopathologically assessed by five pathologists independently. Observational studies have shown that adenomatous polyps occur more frequently in males than in females (14–18). In our series, there was also a male preponderance, with a male to female ratio of 2.2:1. Overall, this study showed that left-sided adenomatous polyps were more prevalent than rightsided ones, which is in line with previous studies (18–21). Furthermore, consistent with previous studies, the sigmoid colon was the most common site of adenomatous polyps in the present study (18, 20). Our results indicated that the interobserver agreement regarding histologic type is moderate (k=0.412). This level of agreement was lower than what was reported by Jensen et al. (k=0.54) (7) and van Putten et al. (k=0.55) (8), but approximately consistent with other studies performed by Yoon et al. (k=0.46), Foss et al. (k=0.0.18, 0.38, and 0.61), and Terry et al. (k=0.48) (9–11). Furthermore, a better agreement was obtained after excluding Pathologists 4 and 5 from the assessments. Consistent with previous studies (k ranging from 0.3 to 0.4) (7, 9, 22), the moderate agreement in assessing dysplasia was obtained among Iranian pathologists in this study (k=0.415). However, several studies have shown a good degree of agreement (k ranging from 0.5 to 0.7) (8, 10, 23, 24). For this feature, a better agreement was also obtained after excluding Pathologist 4 from the assessments. Moreover, agreement on the final diagnosis in colorectal adenomas (i.e., both histologic type and dysplasia grade) was fair in this study, with a kappa value of 0.314. On the other hand, agreement among all five pathologists was seen in 41.8% for the final diagnosis, 51.4% for histologic type, and 71.2% for dysplasia grade. In a study conducted by Jensen et al. (7), the agreements among three pathologists for the final diagnosis, histologic type, and dysplasia grade were 35.2%, 61.0%, 47.8%, respectively. The lowest agreement was found for the mitotic activity, nuclear shape, and nucleolus. For these features, all Kappa values were less than 0.2, indicating a poor level of agreement among pathologists. In this study, fair interobserver agreement was found for the grade of architecture in both the upper and lower halves, as well as for crypts’ configuration. Resection of adenomas eliminates their risk of potential malignant transformation––but not potential for the development of a new metachromatic adenoma or carcinoma. This risk is correlated with the number, localization, size, architecture, and degree of dysplasia of the initially resected adenoma (9). Patients with a resected adenoma, demonstrating the following features: size > 1 cm, villous component, and high-grade dysplasia, have a high risk of recurrence, and should follow up colonoscopy more frequently. Obviously, histomorphology has a significant role in determining high-risk adenoma, which requires intense surveillance to avoid progression to carcinoma, but no study is available regarding the identification of markers for the distinction between low- and high-grade dysplasia. Many molecular markers have been identified in the adenoma-carcinoma transition, starting from APC and TP53 to the more recent BRAF, SKA3, and DSN1, but no investigations have been conducted considering different grades of dysplasia (25). In order to improve the diagnostic accuracy of dysplasia in adenomas, our study suggests that preparing and incorporating a common national guideline, emphasizing two important criteria with more interobserver variabilities (including cytology grade and architectural features with adding images, such as in atlas), could be beneficial. Other works based on molecular study focus on comparing morphological criteria with outcomes, and molecular abnormalities in adenomas also are required. Our study has several strengths that should be mentioned, including (a) evaluating the interobserver agreement via a relatively large number of experienced pathologists in the field of GI pathology in Iran and (b) simultaneously evaluating interobserver agreement for most features of adenomatous polyps. There are also a few limitations that should be considered in evaluating the present findings. First, the sample size was relatively small, and a larger multicenter study would be required to confirm the results. Second, because of the practical reasons, intraobserver agreement was not evaluated in this study. Third, we did not have data on the other types of colorectal polyps.

Conclusion

In sum, the assessment of dysplasia in colorectal adenomas requires careful histopathological evaluation, which, in most cases, appears to be sufficient for proper classification, but interobserver variabilities cannot be ignored. Our findings indicate that agreement among pathologists in assessing dysplasia in colorectal adenomatous polyps is within fair to moderate levels of agreement. It seems as if the diagnostic criteria being limited or divided into a major and minor category could be effective in reducing the variability of intra and inter observers. Improving diagnostic criteria requires to design new standardized protocols and examine them in separate studies. Our findings emphasize improving the existing diagnostic criteria, as well as developing new standardized criteria, besides new histochemical, immunohistochemical, or molecular markers, which could allow to categorize the dysplasia in a more accurate way because the surveillance implications and clinical approach are relevant.
  23 in total

1.  Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology.

Authors:  J H Bond
Journal:  Am J Gastroenterol       Date:  2000-11       Impact factor: 10.864

2.  Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.

Authors:  Monika Ferlitsch; Alan Moss; Cesare Hassan; Pradeep Bhandari; Jean-Marc Dumonceau; Gregorios Paspatis; Rodrigo Jover; Cord Langner; Maxime Bronzwaer; Kumanan Nalankilli; Paul Fockens; Rawi Hazzan; Ian M Gralnek; Michael Gschwantler; Elisabeth Waldmann; Philip Jeschek; Daniela Penz; Denis Heresbach; Leon Moons; Arnaud Lemmers; Konstantina Paraskeva; Juergen Pohl; Thierry Ponchon; Jaroslaw Regula; Alessandro Repici; Matthew D Rutter; Nicholas G Burgess; Michael J Bourke
Journal:  Endoscopy       Date:  2017-02-17       Impact factor: 10.093

3.  Prevalence of polyps and diverticulosis of the large bowel in the Cretan population. An autopsy study.

Authors:  G A Paspatis; N Papanikolaou; E Zois; E Michalodimitrakis
Journal:  Int J Colorectal Dis       Date:  2001-08       Impact factor: 2.571

4.  Inter-observer variability in the histological assessment of colorectal polyps detected through the NHS Bowel Cancer Screening Programme.

Authors:  Fiona A Foss; Steve Milkins; Angus H McGregor
Journal:  Histopathology       Date:  2012-04-04       Impact factor: 5.087

5.  The state of the art of cancer control in 30 European countries in 2008.

Authors:  Joana Bastos; Bárbara Peleteiro; Joaquim Gouveia; Michel P Coleman; Nuno Lunet
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

6.  Interobserver agreement in the reporting of colorectal polyp pathology among bowel cancer screening pathologists in Wales.

Authors:  Jeff K Turner; Geraint T Williams; Meleri Morgan; Melissa Wright; Sunil Dolwani
Journal:  Histopathology       Date:  2013-05       Impact factor: 5.087

7.  Interobserver agreement in the histologic diagnosis of colorectal polyps. the experience of the multicenter adenoma colorectal study (SMAC).

Authors:  Massimo Costantini; Stefania Sciallero; Augusto Giannini; Beatrice Gatteschi; Paolo Rinaldi; Giuseppe Lanzanova; Luigina Bonelli; Tino Casetti; Elisabetta Bertinelli; Orietta Giuliani; Guido Castiglione; Paola Mantellini; Carlo Naldoni; Paolo Bruzzi
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

8.  Left sided colorectal adenomatous polyps have more risk for high grade dysplasia.

Authors:  Ali Zare-Mirzaie; Maryam Abolhasani; Atefeh Aryamanesh
Journal:  Acta Med Iran       Date:  2013-04-06

9.  Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

Authors:  Victoria S Benson; Julietta Patnick; Anna K Davies; Marion R Nadel; Robert A Smith; Wendy S Atkin
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

10.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Tomi F Akinyemiju; Faris Hasan Al Lami; Tahiya Alam; Reza Alizadeh-Navaei; Christine Allen; Ubai Alsharif; Nelson Alvis-Guzman; Erfan Amini; Benjamin O Anderson; Olatunde Aremu; Al Artaman; Solomon Weldegebreal Asgedom; Reza Assadi; Tesfay Mehari Atey; Leticia Avila-Burgos; Ashish Awasthi; Huda Omer Ba Saleem; Aleksandra Barac; James R Bennett; Isabela M Bensenor; Nickhill Bhakta; Hermann Brenner; Lucero Cahuana-Hurtado; Carlos A Castañeda-Orjuela; Ferrán Catalá-López; Jee-Young Jasmine Choi; Devasahayam Jesudas Christopher; Sheng-Chia Chung; Maria Paula Curado; Lalit Dandona; Rakhi Dandona; José das Neves; Subhojit Dey; Samath D Dharmaratne; David Teye Doku; Tim R Driscoll; Manisha Dubey; Hedyeh Ebrahimi; Dumessa Edessa; Ziad El-Khatib; Aman Yesuf Endries; Florian Fischer; Lisa M Force; Kyle J Foreman; Solomon Weldemariam Gebrehiwot; Sameer Vali Gopalani; Giuseppe Grosso; Rahul Gupta; Bishal Gyawali; Randah Ribhi Hamadeh; Samer Hamidi; James Harvey; Hamid Yimam Hassen; Roderick J Hay; Simon I Hay; Behzad Heibati; Molla Kahssay Hiluf; Nobuyuki Horita; H Dean Hosgood; Olayinka S Ilesanmi; Kaire Innos; Farhad Islami; Mihajlo B Jakovljevic; Sarah Charlotte Johnson; Jost B Jonas; Amir Kasaeian; Tesfaye Dessale Kassa; Yousef Saleh Khader; Ejaz Ahmad Khan; Gulfaraz Khan; Young-Ho Khang; Mohammad Hossein Khosravi; Jagdish Khubchandani; Jacek A Kopec; G Anil Kumar; Michael Kutz; Deepesh Pravinkumar Lad; Alessandra Lafranconi; Qing Lan; Yirga Legesse; James Leigh; Shai Linn; Raimundas Lunevicius; Azeem Majeed; Reza Malekzadeh; Deborah Carvalho Malta; Lorenzo G Mantovani; Brian J McMahon; Toni Meier; Yohannes Adama Melaku; Mulugeta Melku; Peter Memiah; Walter Mendoza; Tuomo J Meretoja; Haftay Berhane Mezgebe; Ted R Miller; Shafiu Mohammed; Ali H Mokdad; Mahmood Moosazadeh; Paula Moraga; Seyyed Meysam Mousavi; Vinay Nangia; Cuong Tat Nguyen; Vuong Minh Nong; Felix Akpojene Ogbo; Andrew Toyin Olagunju; Mahesh Pa; Eun-Kee Park; Tejas Patel; David M Pereira; Farhad Pishgar; Maarten J Postma; Farshad Pourmalek; Mostafa Qorbani; Anwar Rafay; Salman Rawaf; David Laith Rawaf; Gholamreza Roshandel; Saeid Safiri; Hamideh Salimzadeh; Juan Ramon Sanabria; Milena M Santric Milicevic; Benn Sartorius; Maheswar Satpathy; Sadaf G Sepanlou; Katya Anne Shackelford; Masood Ali Shaikh; Mahdi Sharif-Alhoseini; Jun She; Min-Jeong Shin; Ivy Shiue; Mark G Shrime; Abiy Hiruye Sinke; Mekonnen Sisay; Amber Sligar; Muawiyyah Babale Sufiyan; Bryan L Sykes; Rafael Tabarés-Seisdedos; Gizachew Assefa Tessema; Roman Topor-Madry; Tung Thanh Tran; Bach Xuan Tran; Kingsley Nnanna Ukwaja; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Elisabete Weiderpass; Hywel C Williams; Nigus Bililign Yimer; Naohiro Yonemoto; Mustafa Z Younis; Christopher J L Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.